help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 21, 2009
Molecular Endocrinology, doi:10.1210/me.2009-0022
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
23/9/1479    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Hanstein, R.
Right arrow Articles by Clement, A. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanstein, R.
Right arrow Articles by Clement, A. B.

Submitted on January 14, 2009
Accepted on May 14, 2009

Increased Cx43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone

Regina Hanstein, Jacqueline Trotter, Christian Behl*, and Angela B. Clement*

Institute of Pathobiochemistry, University Medical Center, Department of Biology, Unit of Molecular Cell Biology, Johannes Gutenberg-University, 55099 Mainz, Germany

* To whom correspondence should be addressed. E-mail: cbehl{at}uni-mainz.de or clemena{at}uni-mainz.de.

Corticotropin-releasing hormone (CRH) is a major central stress mediator, but also a potent neuroprotective effector. The mechanisms by which CRH mediates its neuroprotective actions are largely unknown. Here, we describe that the gap junction molecule connexin43 (Cx43) mediates neuroprotective effects of CRH towards experimentally induced oxidative stress. An enhanced gap junction communication has been reported to contribute to neuroprotection after neurotoxic insults. We show that CRH treatment upregulates Cx43 expression and gap junctional communication in a CRH receptor-dependent manner in IMR32 neuroblastoma cells, primary astrocytes and organotypic hippocampal slice cultures. MAP kinases and PKA-CREB-coupled pathways are involved in the signaling cascade from CRH to enhanced Cx43 function. Inhibition of CRH-promoted gap junction communication by the gap junction inhibitor carbenoxolone could prevent neuroprotective actions of CRH in cell and tissue culture models suggesting that gap junction molecules are involved in the neuroprotective effects of CRH. The extent of oxidative stress-induced protein carbonylation and cell death inversely correlated with Cx43 protein levels as shown by Cx43 siRNA knockdown experiments. Co-culture studies of primary neurons and astrocytes revealed that astrocytic Cx43 likely contributes to the neuroprotective effects of CRH. To our knowledge this is the first description of Cx43 as a potential mediator of the neuroprotective actions of CRH.


Key words: neuroblastoma • astrocytes • hippocampal slice cultures • H2O2 • amyloid {beta} peptide







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society